ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 785

Further Validation of Simple Index As a Simple Disease Activity Assessment Tool for SLE

Nisarg Gandhi1, Meenakshi Jolly2, Alana Nevares3 and Winston Sequeira1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Department of Medicine, Section of Rheumatology, Rush University Medical Center, Chicago, IL, 3Internal Medicine, Cook County Hospital, Chicago, IL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Disease Activity, SLE and patient outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

An easy, quick tool, requiring minimal training or physician input for disease activity (DA) assessment in SLE, would have potentially greater uptake for routine use among rheumatologists and primary care physicians. Furthermore, integration into busy work flow processes would be easier for the same reason. Most DA tools for SLE are complex, require training and physician time; and are not performed during routine care visits for most SLE patients. SIMPLE (Simple Disease Assessment for People with Lupus Erythematosus) ¹ is a numeric composite index based on patient reported questions and two laboratory values, and requires minimal input from health care provider which can be provided by nurse or a physician extender.  Here, we prospectively evaluate the correlation of SIMPLE index with physician based DA measure. 

Methods:

Fifty consenting patients meeting ACR classification criteria for SLE were recruited from two academic center clinics.  Primary outcome of interest was correlation between Simple Index (SI) and SELENA-SLEDAI (SS). Secondary outcome of interest was correlation between SI and Physician Global Assessment (PGA).  Patients filled the self-reported components of SI in the waiting room prior to their visit. PGA, SS and total numeric BILAG were assessed at the same visit by the physician. Descriptive and spearman correlational analyses were obtained. Stratified analysis by fibromyalgia status (FMS) was also conducted. P value of ≤0.05 was considered significant on two tailed tests. We considered correlation coefficient of <0.30, 0.30 to 0.49 and >0.50 as weak, moderate and strong correlation, respectively. 

Results:

Mean (SD) age was 41.4+13 yrs, and 90% participants were women. Ethnic background of the participants was as follows:  56% Blacks, 24% Whites, 10% Asians and 10% others. Median (IQR) SI was 27.8 (18.3). Range for SI was 58.4. Median (IQR) values of PGA, total SS, total numeric BILAG and SDI were 0.5 (0.8), 4.0(6.0), 10.5(9.0) and 1.0(1.0), respectively.  Spearman correlation coefficient between SI and PGA and SS were 0.547 (p 0.001), 0.545(p 0.001), respectively. In a sub analysis excluding fibromyalgia patients, these correlations were 0.718(p 0.001, n=34), 0.622(p 0.001, n=36) respectively. 

Conclusion:

SIMPLE index is strongly correlated with PGA and SS in SLE, and the correlation is even stronger is SLE patients without FMS. It is quick, easy and requires minimal physician input. Larger and longitudinal studies that include patients with greater DA and test responsiveness are currently ongoing.

Reference:

¹ Simple Disease Assessment for People with Lupus Erythematosus. A&R. 2014; 66 (11):s312


Disclosure: N. Gandhi, None; M. Jolly, Pfizer Inc, 7; A. Nevares, None; W. Sequeira, None.

To cite this abstract in AMA style:

Gandhi N, Jolly M, Nevares A, Sequeira W. Further Validation of Simple Index As a Simple Disease Activity Assessment Tool for SLE [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/further-validation-of-simple-index-as-a-simple-disease-activity-assessment-tool-for-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/further-validation-of-simple-index-as-a-simple-disease-activity-assessment-tool-for-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology